Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus

Medicine

Volumn 82, Issue 4, 2003, Pages 225-235

  Aronoff, David M ^a   Bloch, Karen C ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; CORTICOSTEROID; DEXTROPROPOXYPHENE; HYDROCHLOROTHIAZIDE; LEVOFLOXACIN; METHOTREXATE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; OXYCODONE; PARACETAMOL; PENICILLIN G; PREDNISONE; ROFECOXIB; TRIAMTERENE; VANCOMYCIN; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTHRITIS; ARTICLE; BACTERIUM EXAMINATION; BONE PROSTHESIS; CASE REPORT; CAUCASIAN; CELLULITIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONVALESCENCE; DEBRIDEMENT; DISEASE COURSE; DISEASE SEVERITY; DRUG USE; ECCHYMOSIS; EDEMA; ERYTHEMA; FALLING; FEMALE; FEMUR FRACTURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LABORATORY TEST; MALE; MEDICAL LITERATURE; MYALGIA; NECROSIS; NECROTIZING FASCIITIS; NONHUMAN; PAIN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

EID: 0037823449     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000085060.63483.bb     Document Type: Article

References (63)

1. Active bacterial core surveillance (ABCs) report emerging infections program network group A streptococcus, 1998. Vol. 2002. Atlanta: Centers for Disease Control and Prevention, 1999.
2. Active bacterial core surveillance (ABCs) report emerging infections program network group A streptococcus, 1999. Vol. 2002. Atlanta: Centers for Disease Control and Prevention, 2000.
3. Active bacterial core surveillance (ABCs) report emerging infections program network group A streptococcus, 2000 (preliminary). Vol. 2002. Atlanta: Centers for Disease Control and Prevention, 2001.
4. Aronoff DM, Neilson EG. Antipyretics: Mechanisms of action and clinical use in fever suppression. Am J Med 111: 304-15, 2001.
5. Ashbaugh CD, Warren HB, Carey VJ, Wessels MR. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest 102: 550-60, 1998.
6. Barnham M. Nonsteroidal antiinflammatory drugs: Concurrent or causative drugs in serious infection? Clin Infect Dis 25: 1272-3, 1997.
7. Barnham M, Anderson AW. Non-steroidal anti-inflammatory drugs (NSAIDs). A predisposing factor for streptococcal bacteraemia? Adv Exp Med Biol 418: 145-7, 1997.
8. Barnham MR, Weightman NC, Anderson AW, Tanna A. Streptococcal toxic shock syndrome: A description of 14 cases from North Yorkshire, UK. Clin Microbiol Infect 8: 174-81, 2002.
9. Basma H, Norrby-Teglund A, Guedez Y, McGeer A, Low DE, El-Ahmedy O, Schwartz B, Kotb M. Risk factors in the pathogenesis of invasive group A streptococcal infections: Role of protective humoral immunity. Infect Immun 67: 1871-7, 1999.
10. Bisno AL, Cockerill FR III, Bermudez CT. The initial outpatient-physician encounter in group A streptococcal necrotizing fasciitis. Clin Infect Dis 31: 607-8, 2000.
11. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 334: 240-5, 1996.
12. Blatteis CM. Fever: Pathological or physiological, injurious or beneficial? J Thermal Biol 28: 1-13, 2003.
13. Brandts CH, Ndjave M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 350: 704-9, 1997.
14. Brogan TV, Nizet V, Waldhausen JH, Rubens CE, Clarke WR. Group A streptococcal necrotizing fasciitis complicating primary varicella: A series of fourteen patients. Pediatr Infect Dis J 14: 588-94, 1995.
15. Brun-Buisson CJ, Saada M, Trunet P, Rapin M, Roujeau JC, Revuz J. Haemolytic streptococcal gangrene and non-steroidal anti-inflammatory drugs. Br Med J (Clin Res Ed) 290: 1786, 1985.
16. Chelsom J, Halstensen A, Haga T, Hoiby EA. Necrotising fasciitis due to group A streptococci in western Norway: Incidence and clinical features. Lancet 344: 1111-5, 1994.
17. Childers BJ, Potyondy LD, Nachreiner R, Rogers FR, Childers ER, Oberg KC, Hendricks DL, Hardesty RA. Necrotizing fasciitis: A fourteen-year retrospective study of 163 consecutive patients. Am Surg 68: 109-16, 2002.
18. Choo PW, Donahue JG, Platt R. Ibuprofen and skin and soft tissue superinfections in children with varicella. Ann Epidemiol 7: 440-5, 1997.
19. Diazgranados CA, Bisno AL. Clues to the early diagnosis of group A streptococcal necrotizing fasciitis. Infect Med 18: 198-206, 2001.
20. Doran TF, De Angelis C, Baumgardner RA, Mellits ED. Acetaminophen: More harm than good for chickenpox? J Pediatr 114: 1045-8, 1989.
21. Ey JL. Fever: To treat or not to treat. Commentary. Clin Pediatr (Phila) 41: 14-6, 2002.
22. Forbes N, Rankin AP. Necrotizing fasciitis and non steroidal anti-inflammatory drugs: A case series and review of the literature. N Z Med J 114: 3-6, 2001.
23. Ford LM, Waksman J. Necrotizing fasciitis during primary varicella. Pediatrics 105: 1372-3 [discussion pp 1373-5], 2000.
24. Frankish PD, Mason GH, Allen PR, Milsom FP, Christmas TI. Acute streptococcal necrotising fasciitis. N Z Med J 101: 625-6, 1988.
25. Guibal F, Muffat-Joly M, Terris B, Garry L, Morel P, Carbon C. Effects of diclofenac on experimental streptococcal necrotizing fasciitis (NF) in rabbit. Arch Dermatol Res 290: 628-33, 1998.
26. Hasday JD, Fairchild KD, Shanholtz C. The role of fever in the infected host. Microbes Infect 2: 1891-904, 2000.
27. Haywood CT, McGeer A, Low DE. Clinical experience with 20 cases of group A streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997. Plast Reconstr Surg 103: 1567-73, 1999.
28. Hird B, Byrne K. Gangrenous streptococcal myositis: Case report. J Trauma 36: 589-91, 1994.
29. Kahn LH, Styrt BA. Necrotizing soft tissue infections reported with nonsteroidal antiinflammatory drugs. Ann Pharmacother 31: 1034-9, 1997.
30. Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 103: 18-24, 1997.
31. Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D. Role of fever in disease. Ann N Y Acad Sci 856: 224-33, 1998.
32. Krige JE, Spence RA, Potter PC, Terblanche J. Necrotising fasciitis after diflunisal for minor injury. Lancet 2: 1432-3, 1985.
33. Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 105: E60, 2000.
34. Lesko SM, O'Brien KL, Schwartz B, Vezina R, Mitchell AA. Invasive group A streptococcal infection and nonsteroidal anti-inflammatory drug use among children with primary varicella. Pediatrics 107: 1108-15, 2001.
35. Mackowiak PA, Plaisance KI. Benefits and risks of antipyretic therapy. Ann N Y Acad Sci 856: 214-23, 1998.
36. Majeski J. Necrotizing fasciitis developing from a brown recluse spider bite. Am Surg 67: 188-90, 2001.
37. McGeer A, Green K, Schwartz B, Kaul R, Low DE. Do non-steroidal anti-inflammatory drugs (NSAIDS) predispose to severe disease due to group A streptococci (GAS)? Evidence from population-based surveillance, Ontario, Canada, 1992-1995. In: 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Fracisco, California, 1995.
38. O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis 35: 268-76, 2002.
39. Pathmakanthan S, O'Donovan DG, Sheehan KM, Murray FE. Prospective evaluation of the utilization of aspirin and non-steroidal anti-inflammatory drugs in acute medical admissions. Ir Med J 91: 58-60, 1998.
40. Peterson CL, Vugia DJ, Meyers HB, Chao SM, Vogt J, Lanson J, Brunell PA, Kim KS, Mascola L. Risk factors for invasive group A streptococcal infections in children with varicella: A case-control study. Pediatr Infect Dis J 15: 151-6, 1996.
41. Pillans PI, O'Connor N. Tissue necrosis and necrotizing fasciitis after intramuscular administration of diclofenac. Ann Pharmacother 29: 264-6, 1996.
42. Ricketts D, Teale G, Roberts J, O'Malley R. Streptococcal gangrene presenting as hip pain: Two case reports and review of the literature. Injury 23: 134-5, 1992.
43. Rietveld JA, Pilmore HL, Jones PG, Theis JC, Bowie DA, Dempster AG, Walker RJ. Necrotising fasciitis: A single centre's experience. N Z Med J 108: 72-4, 1995.
44. Rimailho A, Riou B, Richard C, Auzepy P. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis 155: 143-6, 1987.
45. Roberts LJ, Morrow JD. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill, pp 687-732, 2001.
46. Roghmann MC, Warner J, Mackowiak PA. The relationship between age and fever magnitude. Am J Med Sci 322: 68-70, 2001.
47. Rowan JA, North RA. Necrotizing fasciitis in the puerperium. Am J Obstet Gynecol 173: 241-2, 1995.
48. Schummer W, Schummer C. Nonsteroidal anti-inflammatory drugs and streptococcal toxic shock syndrome. Intensive Care Med 28: 1194, 2002.
49. Sharkawy A, Low DE, Saginur R, Gregson D, Schwartz B, Jessamine P, Green K, McGeer A. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 34: 454-60, 2002.
50. Simonart T, Simonart JM, Derdelinclcx I, De Dobbeleer G, Verleysen A, Verraes S, de Maubeuge J, Van Vooren JP, Naeyaert JM, de la Brassine M, Peetermans WE, Heenen M. Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis. Clin Infect Dis 32: E9-12, 2001.
51. Smith RJ, Berk SL. Necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. South Med J 84: 785-7, 1991.
52. Solomon L. Activation of latent infection by indomethacin: A report of three cases. Br Med J 1: 961-2, 1966.
53. Stanley ED, Jackson GG, Panusarn C, Rubenis M, Dirda V. Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 231: 1248-51, 1975.
54. Stevens DL. Could nonsteroidal antinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 21: 977-80, 1995.
55. Stevens DL. Streptococcal toxic shock syndrome. Clin Microbiol Infect 8: 133-6, 2002.
56. Swartz MA. Cellulitis and subcutaneous tissue infections. In: Mandell GE, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Vol. 2. 5th ed. Philadelphia: Churchill Livingstone, pp 1037-57, 2000.
57. Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. Faseb J 15: 2057-72, 2001.
58. van Ammers PM, Moore PJ, Sacho H. Necrotising fasciitis after caesarean section-association with non-steroidal anti-inflammatory drugs. A report of 3 cases. S Afr Med J 80: 203-4, 1991.
59. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232-5, 1971.
60. Wilson GJ, Talkington DF, Gruber W, Edwards K, Dermody TS. Group A streptococcal necrotizing fasciitis following varicella in children: Case reports and review. Clin Infect Dis 20: 1333-8, 1995.
61. Wojno K, Spitz WU. Necrotizing fasciitis: A fatal outcome following minor trauma. Case report and literature review. Am J Forensic Med Pathol 10: 239-41, 1989.
62. Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 103: 783-90, 1999.
63. Zurawski CA, Bardsley M, Beall B, Elliott JA, Facklam R, Schwartz B, Farley MM. Invasive group A streptococcal disease in metropolitan Atlanta: A population-based assessment. Clin Infect Dis 27: 150-7, 1998.